You can enrol in up to 20 courses during temporary access. You’ve reached this limit and can’t enrol in any more right now.
Once you have full access, you’ll be able to enrol without limit.
Good nutrition is a vital part of patient care and includes nutrition screening, assessment, and intervention. Nutrition intervention involves many strategies, including food, oral nutritional supplements, tube feeding, and parenteral nutrition.
ONS are supplementary oral intake of dietary food for special medical purposes in addition to the normal food.1 ONS are one important nutrition intervention strategy for patients with poor food intake, low appetite, and those with or at risk of malnutrition. ONS are an effective and non-invasive solution to malnutrition. ONS have been demonstrated to be more effective than dietary advice and snacks; greater intakes of energy, protein, and micronutrients and significantly fewer complications have been shown in patients taking ONS.2
ONS have proven nutritional, functional, clinical, and economic benefits in both the hospital and community setting in a wide variety of patient populations. Studies show that ONS increase energy and protein intake in both hospital and community patients without reducing food/meal intake, and ONS might actually help to stimulate appetite in certain patient groups.2 Research demonstrates that early nutrition intervention, including oral nutritional supplementation, improves outcomes in cancer patients including nutritional status, weight, treatment tolerance, and quality of life.
ONS may provide, maintain, or improve nutritional status in patients with or at risk for malnutrition. In addition to patients with malnutrition, those who are hospitalized for certain conditions and procedures and are prone to poor outcomes (e.g. complications, longer length of stay) may also benefit from oral nutritional supplementation. Additionally, certain populations in the community may benefit from ONS, particularly community-dwelling older adults.
Data from NutritionDay surveys showed that only 5-8% of patients eating half or less of their meals are provided nutrition intervention, including oral nutritional supplements.3
Nutrition intervention, including ONS, can improve outcomes and reduce health care costs. Many studies confirm the benefits of nutrition intervention for malnourished or at risk patients. Providing oral nutritional supplements to these patients helps decrease morbidity and mortality, decrease length of hospital stay, decrease readmission rates, improve quality of life, and decrease health care costs. 4-6
A 2012 meta-analysis confirms these benefits and showed that high protein ONS demonstrated a range of benefits across settings and patient populations including reduced complications, reduced hospital readmissions, improved grip strength, increased protein and energy intake with little reduction in normal food intake, and improvements in body weight.4
1. Lochs H, Allison SP, Meier R, et al. Clin Nutr. Apr 2006;25(2):180-86.
2. Oral Nutritional Supplements to Tackle Malnutrition: A Summary of the Evidence Base. Brussels, Belgium: Medical Nutrition International Industry (MNI);2012.
3. Hiesmayr M, Schindler K, Pernicka E, et al.Clin Nutr. 2009;28:484-91.
4. Cawood AL, Elia M, Stratton RJ. Ageing Res Rev. 2012;11(2):278-96.
5. Gariballa S, Forster S, Walters S, Powers H. Am J Med. Aug 2006;119(8):693-99.
6. Philipson T, Snider T, Lakdawalla D, Stryckman B, Goldman D. Am J Manag Care. 2013;19(2):121-28.
Clinical Summary Overview
Young Clinical Summary
UK-N/A-2200376 | June 2022
SESSION TIMEOUT
Please log in to continue
Thanks for registering. To begin, please log in to your ProConnect account. After you log in, you’ll have temporary access to all resources and education while we verify your details.
Added to Bag
ENSURE PLUS
1 x 220 ml
Flavor: Apple
1,5 kcal / ml
Nutrition Information
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
footnotes
Product details not available.
You have {liteUserDaysLeft} business days of temporary access.
Based on your email address {email} your account has not yet been approved. We’re validating your credentials. You won’t be able to order samples until your account is approved and activated. Please check your email for more details. For help, contact us at abbott.proconnect_access@nhs.net.
UK--2500192 | September 2025
You have {liteUserDaysLeft} business days of temporary access.
Based on your email address {email} your credentials are validated but not yet activated. To gain full access, including the ability to order samples, click the activation link we sent to your inbox. For help, contact us at abbott.proconnect_access@nhs.net.
UK--2500192 | September 2025
Register to continue reading this article
UK-N/A-2400058(v9) | September 2025
You are about to exit for another Abbott country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimised for your specific screen size.
Do you wish to continue and exit this website?
UK-N/A-2200465 | July 2022
This website is for UK HCPs and UK Patients only. If you are outside of the UK please visit our global website Abbott.com
If you choose "I am a patient/carer”, you will be entering a website intended for patients and carers which has information on Abbott products. Products on this website are to be used under medical supervision. If you have questions about the product information discussed on this website, you should consult with your healthcare professional.